medigraphic.com
ISSN 1560-4381 (Print)

2022, Number 1

<< Back Next >>

Correo Científico Médico 2022; 26 (1)

Type I osteogenesis imperfecta: a case report

Guach HDA, Almira GCR

Language: English
References: 13
Page: 227-236
PDF size: 315.64 Kb.


ABSTRACT

The term osteogenesis imperfecta includes several genetic defects of type I collagen, clinically traduced in bone fragility and deformity. The type I or Lobstein variety is the most frequent form of the disease and is characterized by a pattern of autosomal dominant inheritance. The case of a 65-year-old female patient, who came to our medical service at “Lucia Iñiguez Landin” Hospital of Holguin, Cuba, with multiple fractures after a slight fall was reported. She had short stature, a history of multiple fractures along her life, joint hypermobility, and blue grayish bulbar conjunctiva. Given the positive family history and the phenotypic assessment of the clinical picture, the patient was diagnosed with type I osteogenesis imperfecta. A detailed evaluation was carried out and the available medication was prescribed. The diagnostic and therapeutic update on this disease in Cuba is crucial for enhancing life quality of those who are affected.


REFERENCES

  1. Lindahl K, Åström E, Rubin CJ, Grigelioniene G, Malmgren B, Ljunggren Ö, et al. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet.2015[cited 19/12/2019]; 23(8):1042-1050. Available at: https://www.nature.com/articles/ejhg201581

  2. Lim J, Grafe I, Alexander S, Lee B. Genetic causes and mechanisms of osteogenesis imperfecta. Bone 2017. [Cited 19/12/2019]; 102:40-49. Available at:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607741/

  3. Trejo P, Rauch F. Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment. Osteoporos Int. 2016[cited 25/01/2020]; 27(12):3427-3437.Available at:http://publicationslist.org/data/frauch/ref-315/Trejo-2016-Osteogenesis%20imperfecta%20in%20children.pdf

  4. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979; [cited 25/01/2020]; 16(2):101-116. Available at:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1012733/

  5. Tournis S, Dede A. Osteogenesis imperfect-A clinical update. Metabolismo 2018 [cited 26/01/2020];80:27-37. Available at:https://www.sciencedirect.com/science/article/abs/pii/S0026049517301580

  6. Hernández García I, Fernández Martín M, León Pérez S, García García A, Riaño Echenique J. Osteogénesis imperfecta: mosaicismo germinal o evidencia de heterogeneidad genética. Presentación de una familia y revisión bibliográfica. Rev Cubana Pediatr. 2007[cited 26/01/20];79(3). Available at: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312007000300012

  7. García OA, Rives GY, Álvarez BD. Embarazada con Osteogénesis Imperfecta tipo IV. Revista Cubana de Obstetricia y Ginecología. 2019; [cited 28/1/2020]; 45(1):66-73. Available at: http://revginecobstetricia.sld.cu/index.php/gin/article/view/90

  8. Torres Molina A. Huesos de cristal .Presentación de un caso. Medisur 2010[cited 28/01/20];8(4). Available at: http://medisur.sld.cu/index.php/medisur/article/view/1057

  9. Uttarilli A, Shah H, SriLakshmi Bhavani G, Upadhyai P, Shukla A, Girisha KM. Phenotyping and genotyping of skeletal dysplasias: Evolution of a center and a decade of experience in India. Bone. 2019[cited 04/02/2020];120:204-211. Available at:https://www.sciencedirect.com/science/article/abs/pii/S875632821830406X

  10. Gil JA, DeFroda SF, Sindhu K, Cruz AI, Daniels AH. Challenges of Fracture Management for Adults with Osteogenesis Imperfecta. Orthopedics. 2017[cited 25/08/2020];40(1):17-22. Available at: https://journals.healio.com/doi/abs/10.3928/01477447-20161006-04

  11. Vuorimies I, Mäyränpää MK, Valta H, Kröger H, Toiviainen Salo S, Mäkitie O. Bisphosphonate Treatment and the Characteristics of Femoral Fractures in Children With Osteogenesis Imperfecta. J Clin Endocrinol Metab. 2017[cited 04/02/2020];102(4):1333-1339.Available at: https://academic.oup.com/jcem/article/102/4/1333/2913385

  12. Nicol L, Wang Y, Smith R, Sloan J,Cs Nagamani S, Shapiro J, et al. Serum Sclerostin Levels in Adults With Osteogenesis Imperfecta: Comparison With Normal Individuals and Response to Teriparatide Therapy. J Bone Miner Res. 2018[cited 25/08/2020];33(2):307-315 . Available at:https://asbmr.onlinelibrary.wiley.com/doi/full/10.1002/jbmr.3312

  13. Hoyer Kuhn H, Franklin J, Allo G, Kron M, Netzer C, Eysel P, et al. Safety and efficacy of denosumab in children with osteogenesis imperfect-a first prospective trial. J Musculoskelet Neuronal Interact.2016[cited 04/02/2020]16(1):24-32. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089451/




2020     |     www.medigraphic.com